ACS CAN Comments on Global Benchmark for Efficient Drug Pricing (GLOBE) Model proposed rule

ACS CAN filed a comment letter regarding the policies included in the Global Benchmark for Efficient Drug Pricing (GLOBE) Model proposed rule.